Sign inJoin waitlistJoin the waitlist

Aditya Shreenivas

Medical Oncologist · City of Hope National Medical Center

Credentials: · · · · · · · ·

History

City of Hope National Medical Center
Present

Icahn School of Medicine at Mount Sinai
2015–2018
Internal Medicine
BronxCare Health System
2012–2015
Doctor of Medicine
2006–2010

Research

Trastuzumab for the treatment of salivary duct carcinoma
The Oncologist · 2013 · 143 citations
ALK fusions in the pan-cancer setting: another tumor-agnostic target?
Review · npj Precision Oncology · 2023 · First of 7 authors · Corresponding · 97 citations
Lymph node yield, depth of invasion, and survival in node-negative oral cavity cancer
Oral Oncology · 2019 · 28 citations

SL
Sewanti Limaye
12 papers
Razelle Kurzrock
10 papers
Musaddiq Awan
9 papers · 2 as a resident
Joseph Zenga
8 papers
Monica Shukla
8 papers
Stuart Wong
8 papers
Ben George
7 papers
Becky Massey
6 papers
Prashant Kumar
6 papers
Mandana Kamgar
4 papers
Michael Stadler
4 papers
Sakti Chakrabarti
4 papers

Clinical trials

A Study to Evaluate CRB-701 Compared to Investigator's Choice Therapy in Previously Treated Oropharyngeal Squamous Cell Carcinoma
Site PI · Not yet recruiting · Phase 3
Corbus Pharmaceuticals Inc.
2026–2029
Atezolizumab in Combination With a Multi-Kinase Inhibitor for the Treatment of Unresectable, Locally Advanced, or Metastatic Liver Cancer
Site PI · Recruiting · Phase 2
Academic and Community Cancer Research United
2022–2026
Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
Site PI · Recruiting · Phase 1, Phase 2
Inhibrx Biosciences, Inc
2019–2033